You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for METHADONE HYDROCHLORIDE INTENSOL


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for METHADONE HYDROCHLORIDE INTENSOL

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free M0267_SIGMA ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free M3268_SIGMA ⤷  Get Started Free
LGC Standards ⤷  Get Started Free LGCFOR0531.00 ⤷  Get Started Free
LGC Standards ⤷  Get Started Free MM0531.00 ⤷  Get Started Free
Clearsynth ⤷  Get Started Free CS-EB-01318 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: METHADONE HYDROCHLORIDE INTENSOL

Last updated: August 5, 2025


Introduction

Methadone Hydrochloride Intensol is a potent synthetic opioid primarily used for pain management and opioid dependency treatment. As a critical component in pharmaceutical formulations, sourcing high-quality, compliant active pharmaceutical ingredients (APIs) is essential for manufacturing efficacy, safety, and regulatory adherence. This article explores the landscape of bulk API suppliers for Methadone Hydrochloride Intensol, emphasizing quality standards, regional suppliers, regulatory considerations, and trend insights to facilitate informed procurement decisions.

Understanding Methadone Hydrochloride Intensol

Methadone Hydrochloride is a synthetic mu-opioid receptor agonist, with formulations like Intensol designed to optimize bioavailability and dosing efficiency. The API's purity, stability, and consistency directly influence product effectiveness, making supplier selection a critical strategic decision. The global demand driven by opioid replacement therapy and pain management underscores the need for reliable, compliant API sources.


Global API Manufacturing Landscape

1. Major API Manufacturers

Several pharmaceutical API producers worldwide dominate the supply chain for Methadone Hydrochloride, distinguished by their adherence to Good Manufacturing Practices (GMP), certification standards, and capacity:

  • Lupin Limited (India): A leading API manufacturer with extensive experience in opioids, including Methadone Hydrochloride. Their facilities comply with WHO-GMP, and they have established export channels to North America and Europe.

  • Sun Pharmaceutical Industries (India): Offers high-quality APIs with robust quality control protocols. Sun Pharma's large-scale manufacturing ensures consistent supply and competitive pricing.

  • Kusum Pharma (India): Specializes in manufacturing opioids and derivatives, including Methadone Hydrochloride, with a focus on compliance and high purity standards.

  • Indo Pharmaceuticals (India): Provides API manufacturing with GMP certification, catering to global markets, with a track record of supplying bulk quantities.

  • Eli Lilly and Company (USA): Historically involved in opioid manufacturing, though their role in API production for Methadone is generally integrated within their formulation operations, often serving as a grade benchmark.

2. Regional Considerations

  • India and China: Dominant producers offering cost-effective APIs due to manufacturing scale and regulatory investments. However, quality assurance and regulatory compliance must be critically assessed.

  • Europe and North America: Suppliers are fewer but highly regulated, often partnering with global pharmaceutical companies for high-quality APIs compliant with stringent standards like FDA or EMA.


Quality and Regulatory Standards

Ensuring API purity and compliance is vital. The primary standards include:

  • GMP (Good Manufacturing Practice): Mandatory for APIs intended for pharmaceutical use, ensuring consistent quality and safety.

  • US FDA, EMA, and WHO Certification: Suppliers holding certificates from these agencies demonstrate adherence to strict regulatory frameworks.

  • Analytical Data Transparency: Reliable suppliers provide comprehensive analytical reports including HPLC purity profiles, residual solvents, and heavy metal testing.

  • Batch Consistency and Traceability: Critical for meeting regulatory audits and ensuring therapeutic efficacy. Reputable suppliers maintain detailed batch records and quality certifications.


Emerging Trends in API Sourcing

  • Shift towards API API Contract Manufacturing Organizations (CMOs): Large CMOs with validated facilities in India and China are increasingly favored for their cost-efficiency and capacity.

  • Increased Scrutiny on Compliance: Amid geopolitical tensions and regulatory tightening, buyers prioritize suppliers with transparency, accreditation, and proven track records.

  • Digital Platforms and Supplier Databases: Platforms like Pharmaceutics International (PI) and PharmaCompass facilitate supplier verification, compliance checks, and due diligence.

  • Focus on Sustainability and Ethical Sourcing: Regulatory bodies emphasize responsible sourcing, influencing supplier selection criteria.


Supply Chain Challenges and Risk Management

The API supply chain for Methadone Hydrochloride faces several risks:

  • Regulatory Variability: Changes in international drug control policies or manufacturing standards can impact supply continuity.

  • Manufacturing Disruptions: Natural disasters, geopolitical conflicts, or pandemics (e.g., COVID-19) affecting Indian and Chinese manufacturing hubs.

  • Quality Variability: Variations in purity levels or analytical data among suppliers necessitate comprehensive validation processes.

Effective risk mitigation strategies include supplier qualification, maintaining multiple sourcing options, and conducting periodic audits.


Case Studies: Notable API Suppliers

  1. Lupin Limited: Their GMP-compliant API production for Methadone Hydrochloride has been adopted by several generic pharmaceutical companies, emphasizing consistent quality and supply continuity.

  2. Sun Pharmaceutical: Their registered API manufacturing facilities are certified by global authorities, demonstrating capacity for large-scale, compliant production.

  3. Indo Pharmaceuticals: Recognized for competitive pricing and reliable delivery, their APIs meet pharmacopeia specifications and are tested rigorously before shipment.


Certification and Due Diligence

Prospective buyers must prioritize suppliers:

  • With valid GMP, ISO, or equivalent certifications.
  • That provide detailed analytical and stability data.
  • With documented compliance to international regulations.
  • Demonstrating traceability and ability to scale production.

Performing qualification audits and requesting sample testing remains essential to validate supplier claims.


Future Outlook

The API sourcing landscape for Methadone Hydrochloride Intensol is poised to evolve with regulatory tightenings, supply chain digitalization, and increasing emphasis on quality assurance. Suppliers investing in advanced manufacturing technology, quality systems, and compliance will dominate procurement landscapes.

The growing focus on responsible sourcing introduces additional scrutiny, influencing supplier choice beyond price considerations. As regulatory frameworks tighten, only suppliers with proven compliance and certification will sustain long-term partnerships.


Key Takeaways

  • Global supply options are primarily concentrated in India and China, with high-quality, GMP-certified sources available for Methadone Hydrochloride Intensol.

  • Regulatory compliance remains a critical selection criterion; buyers should prioritize suppliers with recognized certifications such as WHO-GMP, FDA, or EMA.

  • Quality assurance and analytical transparency are essential; comprehensive testing reports facilitate due diligence.

  • Diversification and risk management strategies are vital for supply chain resilience, especially considering geopolitical and manufacturing risks.

  • Emerging trends, such as increased digital sourcing platforms and sustainability considerations, influence procurement decisions.


FAQs

Q1: What are the key quality standards to verify when sourcing Methadone Hydrochloride APIs?
Manufacturers should hold GMP certification, provide comprehensive analytical data (HPLC purity, residual solvents, heavy metals), and demonstrate compliance with relevant international pharmacopeia standards.

Q2: Are Indian and Chinese API suppliers reliable for Methadone Hydrochloride?
Yes, many Indian and Chinese manufacturers comply with GMP and have ISO certifications. Due diligence, certification verification, and quality validation are essential before sourcing.

Q3: How can buyers mitigate risks related to API supply disruptions?
By establishing relationships with multiple qualified suppliers, maintaining safety stock, conducting periodic audits, and keeping abreast of regulatory changes impacting manufacturing locales.

Q4: What regulations impact the international sourcing of Methadone Hydrochloride APIs?
Regulations from agencies like the FDA, EMA, WHO, and national drug enforcement agencies influence sourcing. Compliance with controlled substances regulations is also mandated.

Q5: How does digitalization affect API sourcing for Methadone Hydrochloride?
Digital platforms enable more transparent supplier verification, real-time compliance monitoring, and streamlined due diligence, improving supply chain resilience.


References

  1. [1] WHO Guidelines for the Quality Assurance of Pharmaceuticals, WHO.
  2. [2] US FDA – Drug Master Files and API Certification Standards.
  3. [3] PharmaCompass API Supplier Database.
  4. [4] Indian Pharmaceutical Alliance – API Manufacturing Standards.
  5. [5] European Medicines Agency – Quality Requirements for APIs.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.